GYRE
LIVE

Serial Number

99248264

Owner

Gyre Therapeutics, Inc.

Attorney

Khanh T. Glatzel

First Use Date

Oct 30, 2023

Filing Date

Jun 23, 2025

Add to watchlist:

No watchlists yet
View on USPTO

GYRE Trademark

Serial Number: 99248264

GYRE is a trademark filed by Gyre Therapeutics, Inc. on June 23, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Gyre Therapeutics, Inc. (2 trademarks)

12770 High Bluff Drive, Suite 150
San Diego, CA 92130

Entity Type: 03

Trademark Details

Filing Date

June 23, 2025

Registration Date

Not Registered

First Use Anywhere

October 30, 2023

First Use in Commerce

October 30, 2023

Published for Opposition

June 23, 2026

Goods & Services

Pharmaceutical preparations for the treatment and prevention of chronic obstructive pulmonary disease, pulmonary arterial hypertension, acute liver failure, acute-on-chronic liver failure, liver fibrosis, metabolic dysfunction associated fatty liver disease, nonalcoholic steatohepatitis, idiopathic pulmonary fibrosis, lung fibrosis, organ fibrosis, and inflammatory diseases; each of the foregoing excluding those featuring oral vaporizers for smoking purposes and oral vaporizers for smokers

Conducting early evaluations in the field of new pharmaceuticals; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Testing of pharmaceuticals; each of the foregoing excluding those featuring oral vaporizers for smoking purposes and oral vaporizers for smokers

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
May 27, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 22, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
May 22, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
May 22, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 22, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 4, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 4, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 4, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Feb 13, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Feb 13, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 19, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 19, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 19, 2025 CNRT
ASSIGNED TO EXAMINER
Nov 12, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 30, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jun 23, 2025 MAFR
NEW APPLICATION ENTERED
Jun 23, 2025 NWAP